Damora Therapeutics, Inc. (DMRA)
30.62
+0.31
(+1.02%)
USD |
NASDAQ |
Aug 25, 16:00
30.74
+0.12
(+0.39%)
Pre-Market: 19:59
Damora Therapeutics Total Liabilities (Quarterly) : 27.58M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.58M |
| March 31, 2026 | 25.18M |
| December 31, 2025 | 21.49M |
| September 30, 2025 | 4.07M |
| June 30, 2025 | 4.079M |
| March 31, 2025 | 3.016M |
| December 31, 2024 | 2.661M |
| September 30, 2024 | 2.441M |
| June 30, 2024 | 3.709M |
| March 31, 2024 | 4.318M |
| December 31, 2023 | 5.896M |
| September 30, 2023 | 12.67M |
| Date | Value |
|---|---|
| June 30, 2023 | 15.10M |
| March 31, 2023 | 14.30M |
| December 31, 2022 | 11.44M |
| September 30, 2022 | 9.298M |
| June 30, 2022 | 7.793M |
| March 31, 2022 | 7.616M |
| December 31, 2021 | 4.992M |
| September 30, 2021 | 6.254M |
| June 30, 2021 | 5.39M |
| March 31, 2021 | 6.084M |
| December 31, 2020 | 6.107M |
| September 30, 2020 | 8.87M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 543.64M |
| Shareholders Equity (Quarterly) | 516.06M |
| Current Ratio | 19.73 |
| Net Debt Paydown Yield | 0.02% |